US Bancorp
- SEC CIK
- 0000036104
- Latest filing
- Aug 12, 2026
KROS holding history
Keros Therapeutics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KROS overviewAll 13F holders of KROSFull Q2 2026 holdings
- Shares (Q2 2026)
- 10
- Value
- $107
- % of portfolio
- <0.1%
- Quarters held
- 19
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 10 | $107 | <0.1% | −25−71.4% | Reduced | Holders |
| Q1 2026 | 35 | $386 | <0.1% | −499−93.4% | Reduced | Holders |
| Q4 2025 | 534 | $10.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 534 | $8.45K | <0.1% | −9,330−94.6% | Reduced | Holders |
| Q2 2025 | 9,864 | $131.7K | <0.1% | +9,848+61,550.0% | Added | Holders |
| Q1 2025 | 16 | $163 | <0.1% | −174−91.6% | Reduced | Holders |
| Q4 2024 | 190 | $3.01K | <0.1% | −57−23.1% | Reduced | Holders |
| Q3 2024 | 247 | $14.3K | <0.1% | −38−13.3% | Reduced | Holders |
| Q2 2024 | 285 | $13.0K | <0.1% | −110−27.8% | Reduced | Holders |
| Q1 2024 | 395 | $26.1K | <0.1% | +48+13.8% | Added | Holders |
| Q4 2023 | 347 | $13.8K | <0.1% | +347 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −55−100.0% | Sold out | Holders |
| Q2 2023 | 55 | $2.21K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 55 | $2.35K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 55 | $2.64K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 55 | $2.00K | <0.1% | +14+34.1% | Added | Holders |
| Q2 2022 | 41 | $1.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 41 | $2.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 41 | $2.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 41 | $2.00K | <0.1% | +41 | New | Holders |